State Street Corp Lineage Cell Therapeutics, Inc. Transaction History

State Street Corp

  • $2.47 Trillion
  • Q4 2024

A detailed history of State Street Corp transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,674,512 shares of LCTX stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,674,512
Previous 2,608,352 2.54%
Holding current value
$1.82 Million
Previous $2.37 Million 43.66%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.5 - $0.95 $33,080 - $62,852
66,160 Added 2.54%
2,674,512 $1.34 Million
Q3 2024

Nov 14, 2024
BUY
$0.8 - $1.12 $36,386 - $50,940
45,483 Added 1.77%
2,608,352 $2.37 Million
Q2 2024

Aug 14, 2024
BUY
$0.89 - $1.47 $343,237 - $566,920
385,660 Added 17.71%
2,562,869 $2.56 Million
Q1 2024

May 15, 2024
BUY
$0.86 - $1.48 $69,316 - $119,288
80,600 Added 3.84%
2,177,209 $3.22 Million
Q4 2023

Feb 14, 2024
BUY
$0.91 - $1.35 $67,124 - $99,580
73,763 Added 3.65%
2,096,609 $2.29 Million
Q3 2023

Nov 14, 2023
BUY
$1.16 - $1.53 $97,595 - $128,725
84,134 Added 4.34%
2,022,846 $2.39 Million
Q2 2023

Aug 14, 2023
BUY
$1.26 - $1.53 $1.89 Million - $2.3 Million
1,501,216 Added 343.14%
1,938,712 $2.73 Million
Q4 2022

Feb 14, 2023
SELL
$1.02 - $1.5 $2,652 - $3,900
-2,600 Reduced 0.59%
437,496 $511,000
Q2 2022

Aug 15, 2022
SELL
$1.12 - $1.61 $1.86 Million - $2.68 Million
-1,665,011 Reduced 79.09%
440,096 $695,000
Q1 2022

May 16, 2022
BUY
$1.21 - $2.48 $37,356 - $76,565
30,873 Added 1.49%
2,105,107 $3.24 Million
Q4 2021

Feb 14, 2022
SELL
$1.84 - $2.68 $6.23 Million - $9.07 Million
-3,384,217 Reduced 62.0%
2,074,234 $5.08 Million
Q3 2021

Nov 15, 2021
BUY
$2.26 - $2.86 $8.11 Million - $10.3 Million
3,590,405 Added 192.2%
5,458,451 $13.8 Million
Q2 2021

Aug 16, 2021
BUY
$2.17 - $3.0 $3.91 Million - $5.41 Million
1,802,392 Added 2745.29%
1,868,046 $5.32 Million
Q1 2021

May 17, 2021
BUY
$1.77 - $3.1 $13,275 - $23,250
7,500 Added 12.9%
65,654 $154,000
Q2 2020

Aug 14, 2020
SELL
$0.71 - $1.18 $1.2 Million - $2 Million
-1,695,837 Reduced 96.68%
58,154 $51,000
Q1 2020

May 11, 2020
BUY
$0.6 - $1.58 $1.05 Million - $2.77 Million
1,753,991 New
1,753,991 $1.45 Million

Others Institutions Holding LCTX

# of Institutions
134
Shares Held
106M
Call Options Held
22.1K
Put Options Held
0
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $115M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email